Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase.
作者信息
Reid J L, Calne D B, Vakil S D, Allen J G, Davies C A
出版信息
J Neurol Sci. 1972 Sep;17(1):45-51. doi: 10.1016/0022-510x(72)90021-4.
PMID:4560435
Abstract
摘要
相似文献
1
Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase.
J Neurol Sci. 1972 Sep;17(1):45-51. doi: 10.1016/0022-510x(72)90021-4.
2
Modification of levodopa effect by systemic decarboxylase inhibition.
Arch Neurol. 1973 Feb;28(2):91-5. doi: 10.1001/archneur.1973.00490200039004.
3
Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
Med J Aust. 1974 Mar 23;1(12):429-32.
4
[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].
Wien Med Wochenschr. 1974 Jun 1;124(22):340-4.
5
[Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study].
Nouv Presse Med. 1973 Feb 3;2(5):315-6.
6
"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine.
Neurology. 1974 May;24(5):431-41. doi: 10.1212/wnl.24.5.431.
7
[Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study].
Schweiz Med Wochenschr. 1973 Oct 20;103(42):1466-74.
8
[Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].
Fortschr Neurol Psychiatr Grenzgeb. 1972 Oct;40(10):564-8.
9
[Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].
Arch Psychiatr Nervenkr (1970). 1973 Mar 19;217(1):95-112. doi: 10.1007/BF02552835.
10
[Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
Rev Med Chil. 1973 Jun;101(6):452-5.
引用本文的文献
1
Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.
J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1672-7. doi: 10.1136/jnnp.2003.028761.
2
"On-off" phenomena related to high plasma levodopa.
Br Med J. 1973 Jun 16;2(5867):641-3. doi: 10.1136/bmj.2.5867.641.
3
Gout induced by L-dopa and decarboxylase inhibitors.
Postgrad Med J. 1976 Apr;52(606):232-3. doi: 10.1136/pgmj.52.606.232.
4
Clinical pharmacokinetics of levodopa in parkinson's disease.
Clin Pharmacokinet. 1976;1(5):313-38. doi: 10.2165/00003088-197601050-00001.
5
Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.
Drugs. 1976;11(5):329-77. doi: 10.2165/00003495-197611050-00001.
Zotero 插件